Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eton Pharmaceutcials Inc
(NQ:
ETON
)
4.540
+0.290 (+6.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
223,753
Open
4.230
Bid (Size)
4.500 (1)
Ask (Size)
4.630 (2)
Prev. Close
4.250
Today's Range
4.230 - 4.630
52wk Range
3.030 - 5.810
Shares Outstanding
25,688,062
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
August 22, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
August 08, 2024
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-1.09%
-1.09%
1 Month
+27.17%
+27.17%
3 Month
+26.11%
+26.11%
6 Month
+1.57%
+1.57%
1 Year
-6.78%
-6.78%
More News
Read More
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 30, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Recap: Eton Pharmaceuticals Q4 Earnings
March 14, 2024
Via
Benzinga
Eton Pharmaceuticals Earnings Preview
March 13, 2024
Via
Benzinga
Is NASDAQ:ETON suited for growth investing?
March 06, 2024
Via
Chartmill
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
July 17, 2024
Via
ACCESSWIRE
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
July 15, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
ETON Stock Earnings: Eton Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
May 09, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Why the growth investor may take a look at NASDAQ:ETON.
February 14, 2024
Via
Chartmill
Evaluating NASDAQ:ETON for Growth Investment Opportunities.
January 22, 2024
Via
Chartmill
Eton Pharmaceuticals: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
May 01, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
April 30, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
April 29, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 22, 2024
Via
Benzinga
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
March 22, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
March 14, 2024
Via
InvestorPlace
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
February 29, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Earnings Scheduled For March 14, 2024
March 14, 2024
Via
Benzinga
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
February 21, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
February 02, 2024
From
Eton Pharmaceuticals
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.